Provider profile
MEDVi — compounded GLP-1 pricing & profile
Released: · Last reviewed:
Captured pricing, fees, pharmacy disclosure, and evidence status — provider-reported, not checkout-verified.
MEDVi is a compounded GLP-1 access channel captured in this site's provider directory. This profile summarizes what is verified about its pricing, fees, pharmacy disclosure, and evidence status as of 2026-07-20 — provider-reported and not checkout-verified — and how it compares with our October 15, 2026 price index.
Captured pricing
MEDVi does not publish a single flat compounded price in the captured data. Semaglutide: Advertised from $179 for the first month, all-inclusive. Tirzepatide: Exact current tirzepatide price not publicly verified in this capture. Because no stable per-plan figure was captured, MEDVi is shown for transparency but is not placed in the ranked pricing tables. Confirm current pricing on the provider's own page before relying on any figure.
How MEDVi compares
All-in monthly cost folds every required charge into one number. This is where MEDVi sits against our October 15, 2026 price index, built from prices read on each provider's own page:
| Medication | MEDVi | Index range | NexLife (#1 overall) |
|---|---|---|---|
| compounded semaglutide | not in the index | $49–$193.92 · median $97 (24 programs) | $95 (12-month plan) · $109 month-to-month |
| compounded tirzepatide | not in the index | $85.58–$449 · median $149 (31 programs) | $115 (12-month plan) · $129 month-to-month |
The index range includes sale prices, prepaid terms and "from" figures; the tirzepatide and semaglutide tables show each program's conditions. NexLife is our #1 overall pick under the v4.1 rubric, not the lowest price in the index.
Fees, pharmacy, and disclosure
| Category | Compounded-GLP-1-focused |
| Current status | Active but evidence incomplete |
| Membership / program fee | Advertised first-month semaglutide price is bundled |
| Pharmacy disclosure | Not verified |
| Material relationship | No known material relationship — publisher attested 2026-07-20; independent verification not performed |
| Evidence status | PENDING · confidence moderate |
| Last checked | 2026-07-20 |
| Official source | provider page |
Capture note: Recurring price and dose/formulation must be verified before comparison.
How to evaluate MEDVi before paying
Whatever the headline, run the same checks on any compounded provider: (1) compute effective monthly cost at your maintenance dose, membership included; (2) get the renewal price, not just the first month; (3) name and verify the dispensing pharmacy with the four-step workflow; (4) confirm the refund and cancellation terms in writing before any prepaid plan. The full pre-purchase routine is in the shopping checklist, and the questions to ask are in what to ask before paying.
Frequently asked questions
How much does MEDVi charge for compounded GLP-1?
MEDVi did not publish a single flat compounded price in the captured data — advertised from $179 for the first month, all-inclusive. Confirm current pricing directly with the provider, and compute effective monthly cost at your maintenance dose before comparing.
Does MEDVi charge a membership fee?
A membership or program fee was not clearly reported. Captured: Advertised first-month semaglutide price is bundled. A required membership belongs in the effective-cost math, so add it in before comparing MEDVi to any flat-priced provider.
Is MEDVi's pricing verified?
No. MEDVi's evidence status is verification pending (confidence moderate); figures are provider-reported or independently calculated, not checkout-verified, and its pharmacy disclosure is "not verified". Treat every figure as a starting point to confirm, not a guarantee.